Published in Pharmacol Toxicol on October 01, 1991
Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol (1978) 1.33
Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin. Proc Natl Acad Sci U S A (1980) 1.28
Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane. Proc Natl Acad Sci U S A (1980) 1.11
Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Mol Pharmacol (1980) 1.09
Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett (1990) 1.07
The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther (1990) 1.03
M3 muscarinic acetylcholine receptors regulate cytoplasmic myosin by a process involving RhoA and requiring conventional protein kinase C isoforms. J Biol Chem (1999) 1.01
Electrophysiological and biochemical studies on enhancement of desensitization by phenothiazine neuroleptics. Proc Natl Acad Sci U S A (1983) 0.96
[3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Proc Natl Acad Sci U S A (1980) 0.94
Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neurosci Lett (1990) 0.94
Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol (1995) 0.92
Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol (1977) 0.91
Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors. Mol Pharmacol (1989) 0.91
The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Mol Pharmacol (1984) 0.90
Structural and stereochemical requirements for muscarinic receptor binding. Mol Pharmacol (1979) 0.90
Similarities in the binding sites of the muscarinic receptor and the ionic channel of the nicotinic receptor. Biochem Pharmacol (1980) 0.90
Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle. Mol Pharmacol (1980) 0.90
Sites of action of phencyclidine. III. Interactions with muscarinic receptors. Mol Pharmacol (1980) 0.89
Nature of regional and chemically-induced differences in the binding properties of muscarinic acetylcholine receptors from rat brain. Neuropharmacology (1980) 0.89
5,8-disubstituted indolizidines: a new class of noncompetitive blockers for nicotinic receptor-channels. Neurochem Res (1991) 0.89
Solubilization of muscarinic acetylcholine receptors of bovine brain. Life Sci (1978) 0.89
Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse. J Pharmacol Exp Ther (1986) 0.87
Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax. Neurochem Res (1986) 0.86
Involvement of cytoskeleton in polypeptide hormone secretion from the anterior pituitary lobe: a review. Mol Cell Endocrinol (1990) 0.86
Cholinergic supersensitivity and decreased number of muscarinic receptors in atria from short-term diabetic rats. J Mol Cell Cardiol (1984) 0.85
Effects of adenosine and analogs on adenylate cyclase activity in cultured bovine aortic endothelial cells. Biochem Pharmacol (1990) 0.85
Ketamine inhibition of ligand binding to cholinergic receptors and ion channels. Eur J Pharmacol (1982) 0.84
Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility. Brain Res (1979) 0.84
Regulation of [3H]perhydrohistrionicotoxin binding to Torpedo ocellata electroplax by effectors of the acetylcholine receptor. J Biol Chem (1981) 0.84
Influence of N-ethylmaleimide on cholinoceptors and responses in longitudinal muscles from guinea-pig ileum. Br J Pharmacol (1982) 0.84
Changes in cholinergic parameters associated with failure of conotruncal septation in embryonic chick hearts after neural crest ablation. Circ Res (1985) 0.84
Clonidine protection from soman and echothiophate toxicity in mice. Life Sci (1986) 0.84
Muscarinic cholinergic binding in human erythrocyte membranes. Life Sci (1977) 0.84
Involvement of protein kinase C and protein kinase A in the muscarinic receptor signalling pathways mediating phospholipase C activation, arachidonic acid release and calcium mobilisation. Cell Signal (1999) 0.83
Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state. Neurochem Res (1986) 0.82
Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci Lett (1989) 0.82
Decahydroquinoline alkaloids: noncompetitive blockers for nicotinic acetylcholine receptor-channels in pheochromocytoma cells and Torpedo electroplax. Neurochem Res (1991) 0.82
Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes. J Pharmacol Exp Ther (1990) 0.82
Effect of colchicine and taxol on stimulation of G protein GTPase activity in anterior pituitary lobe of rats by gonadotrophin- and thyrotrophin-releasing hormones. J Reprod Fertil (1993) 0.81
Interactions of tricyclic antidepressants with a synaptic ion channel. Life Sci (1981) 0.81
Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells. Mol Pharmacol (1985) 0.80
Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies. Mol Pharmacol (1984) 0.80
Reversible conversion between affinity states for agonists of the muscarinic acetylcholine receptor from rat brain. Biochem Pharmacol (1979) 0.79
Pyrazole, an alcohol dehydrogenase inhibitor, has dual effects on N-methyl-D-aspartate receptors of hippocampal pyramidal cells: agonist and noncompetitive antagonist. J Pharmacol Exp Ther (1992) 0.79
Altered muscarinic receptor properties and function in the heart in diabetes. J Pharmacol Exp Ther (1987) 0.79
Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. J Pharmacol Exp Ther (1991) 0.79
A novel agonist binding site on nicotinic acetylcholine receptors. J Recept Res (1993) 0.79
Benzomorphan interactions with acetylcholine receptor complexes from Torpedo. Eur J Pharmacol (1983) 0.78
Precursors of cholinergic false transmitters: central effects on blood pressure and direct interactions with cholinergic receptors. Neuropharmacology (1988) 0.78
Adrenergic agonists protect against soman, an irreversible acetylcholinesterase inhibitor. Toxicol Lett (1987) 0.78
Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman. Neurotoxicol Teratol (1989) 0.77
Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat. Neuropharmacology (1987) 0.77
Muscarinic acetylcholine receptors in chick heart: influence of heat and N-ethylmaleimide on receptor conformations and interactions with guanine nucleotide-dependent regulatory proteins. Neurosci Lett (1985) 0.77
Substance P receptor desensitization in the dorsal horn: possible involvement of receptor-G protein complexes. Brain Res (1993) 0.77
Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate-stimulated [3H]MK-801 binding and reversal by glycine. Neurosci Lett (1991) 0.77
Modulation of adenylate cyclase activity in cultured bovine pulmonary arterial endothelial cells. Effects of adenosine and derivatives. Biochem Pharmacol (1989) 0.77
The influence of isoflurane on the synaptic activity of 5-hydroxytryptamine. Neurochem Res (1990) 0.77
Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor. Toxicol Lett (1988) 0.77
Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine. Pharmacol Biochem Behav (1988) 0.77
Retinoic acid-induced differentiation of a human neuroblastoma cell line alters muscarinic receptor expression. Brain Res Dev Brain Res (1993) 0.77
Regulation of beta-adrenergic receptor density in the non-innervated and denervated embryonic chick heart. J Mol Cell Cardiol (1986) 0.77
Characterization of the muscarinic receptor subtypes in the bovine corneal epithelial cells. J Ocul Pharmacol Ther (1996) 0.77
Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain. Neuropharmacology (1991) 0.77
Effect of pH on muscarinic acetylcholine receptors from rat brainstem. J Neurochem (1986) 0.76
Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. Mol Pharmacol (1986) 0.76
Influence of acute and chronic ethanol treatment on muscarinic responses and receptor expression in Chinese hamster ovary cells. Biochem Pharmacol (1997) 0.76
Anatoxin-a interactions with cholinergic synaptic molecules. Proc Natl Acad Sci U S A (1981) 0.75
Protection by clonidine from the cardiovascular changes and lethality following soman administration in the rat: role of brain acetylcholine. Toxicol Appl Pharmacol (1988) 0.75
Clonidine prevents the short-term down regulation of muscarinic receptors in mouse brain induced by the acetylcholinesterase inhibitor soman. Neurosci Lett (1987) 0.75
Role of phospholipids in muscarinic binding by neural membranes. Biochem Pharmacol (1977) 0.75
Effect of ovine prolactin on tubulin function in the anterior pituitary lobe of the lactating rat. Endocrinology (1990) 0.75
Cholinergic actions of false neurotransmitters: acetyldiethylcholine. Neurosci Lett (1982) 0.75
Halothane effects on muscarinic acetylcholine receptor complexes in rat brain. Biochem Pharmacol (1986) 0.75
Selective antagonism by clonidine of the stereotyped and non-stereotyped motor activity elicited by atropine. Pharmacol Biochem Behav (1986) 0.75
Progesterone, testosterone and estradiol-17 beta inhibit gonadotropin-releasing hormone stimulation of G protein GTPase activity in plasma membranes from rat anterior pituitary lobe. Acta Endocrinol (Copenh) (1992) 0.75
Cholinergic actions of false neurotransmitters: acetylpyrrolidinecholine. Neurosci Lett (1981) 0.75
Transition and heavy metal inhibition of ligand binding to muscarinic acetylcholine receptors from rat brain. Toxicol Appl Pharmacol (1979) 0.75
High-affinity agonist binding to rat brainstem muscarinic receptors is eliminated by low pH. Neurosci Lett (1986) 0.75
Binding of [3H]perhydrohistrionicotoxin and [3H]phencyclidine to the nicotinic receptor-ion channel complex of Torpedo electroplax. Inhibition by histrionicotoxins and derivatives. Biochem Pharmacol (1985) 0.75
Gonadotropin-releasing hormone and thyrotropin-releasing hormone regulation of g protein function in the rat anterior pituitary lobe. J Neuroendocrinol (1990) 0.75
Biphasic regulation of detergent-solubilized muscarinic acetylcholine receptors from rat cerebral cortex by N-ethylmaleimide. Res Commun Chem Pathol Pharmacol (1985) 0.75
Tricyclic antidepressant inhibition of depolarization-induced uptake of calcium by synaptosomes from rat brain. Biochem Pharmacol (1985) 0.75
Ethanol disrupts carbamylcholine-stimulated release of arachidonic acid from Chinese hamster ovary cells expressing different subtypes of human muscarinic receptor. Alcohol Clin Exp Res (1998) 0.75
3-Chlorodibenzazepine binding to cholinergic receptors and ion channels. Res Commun Chem Pathol Pharmacol (1981) 0.75
Spermidine attenuation of volatile anesthetic inhibition of glutamate-stimulated [3H](5D,10S)-(+)-methyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine ([3H]MK-801) binding to N-methyl-D-aspartate (NMDA) receptors in rat brain. Biochem Pharmacol (1995) 0.75
N-methylanatoxinol isomers: derivatives of the agonist (+)-anatoxin-a block the nicotinic acetylcholine receptor ion channel. Mol Pharmacol (1989) 0.75
Halothane attenuation of muscarinic inhibition of adenylate cyclase in rat heart. Biochem Pharmacol (1988) 0.75
Influence of halothane on the interactions of serotonin1A and adenosine A1 receptors with G proteins in rat brain membranes. Biochem Pharmacol (1991) 0.75
Acetylcholine stimulates GTP binding to G proteins in rat striatum. Neuroreport (1991) 0.75
Influence of phospholipase C on muscarinic acetylcholine receptor binding in rat brain. Neurochem Res (1984) 0.75
Influence of anti-tubulin antibodies on muscarinic receptor modulation of G protein GTPase activity in rat striatum. Biochem Pharmacol (1990) 0.75
Interactions of chlordecone (kepone) and mirex with the nicotinic acetylcholine receptor--ion channel complex. Toxicol Lett (1986) 0.75
Influence of sulfhydryl reagents on potassium-stimulated calcium uptake by rat brain synaptosomes. Res Commun Chem Pathol Pharmacol (1984) 0.75
Test-tube equilibration of volatile anaesthetic concentrations. Br J Anaesth (1993) 0.75
Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers. Neurochem Res (1991) 0.75
Diethyl ether effects on muscarinic acetylcholine receptor complexes in rat brainstem. Biochem Pharmacol (1988) 0.75
Role of prostanoids in the regulation of central cholinergic receptor sensitivity. J Pharmacol Exp Ther (1993) 0.75
Regional heterogeneity of muscarinic acetylcholine receptors from rat brain is retained after detergent solubilization. Neurosci Lett (1985) 0.75
Stimulation of the release of [32P]guanosine 5'-diphosphate from G proteins in the rat anterior pituitary lobe by gonadotrophin-releasing and thyrotrophin-releasing hormones. J Reprod Fertil (1992) 0.75